scout
|Videos|October 26, 2016

Results of a Trial Comparing Cabozantinib and Sunitinib in mRCC

Toni Choueiri, MD, discusses the results of the ALLIANCE A031203 trial comparing cabozantinib and sunitinib in metastatic renal cell carcinoma (mRCC).

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME